Zobrazeno 1 - 10 of 19 pro vyhledávání: '"Kuiper JL"'
1
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
4
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
5
Akademický článek
Trastuzumab and paclitaxel in patients with EGFR mutated NSCLC that express HER2 after progression on EGFR TKI treatment.
Autor: de Langen AJ; Department of Thoracic Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. j.d.langen@nki.nl.; Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands. j.d.langen@nki.nl., Jebbink M; Department of Thoracic Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Hashemi SMS; Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands., Kuiper JL; Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands., de Bruin-Visser J; Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands., Monkhorst K; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands., Thunnissen E; Department of Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Smit EF; Department of Thoracic Oncology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands.
Publikováno v: British journal of cancer [Br J Cancer] 2018 Aug; Vol. 119 (5), pp. 558-564. Date of Electronic Publication: 2018 Jul 31.
Zobrazit plný text záznamu
6
Akademický článek
Overall survival in EGFR mutated non-small-cell lung cancer patients treated with afatinib after EGFR TKI and resistant mechanisms upon disease progression.
Autor: van der Wekken AJ; Department of Pulmonary Diseases, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands., Kuiper JL; Department of Pulmonary Diseases, VU University Medical Centre, Amsterdam, Netherlands., Saber A; Department of Pathology and Medical Biology, Groningen, University of Groningen, Groningen, Netherlands., Terpstra MM; University of Groningen, Department of Genetics, Groningen, Netherlands., Wei J; University of Groningen, Department of Genetics, Groningen, Netherlands., Hiltermann TJN; Department of Pulmonary Diseases, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands., Thunnissen E; Department of Pathology, VU University Medical Centre, Amsterdam, Netherlands., Heideman DAM; Department of Pathology, VU University Medical Centre, Amsterdam, Netherlands., Timens W; Department of Pathology and Medical Biology, Groningen, University of Groningen, Groningen, Netherlands., Schuuring E; Department of Pathology and Medical Biology, Groningen, University of Groningen, Groningen, Netherlands., Kok K; University of Groningen, Department of Genetics, Groningen, Netherlands., Smit EF; Department of Pulmonary Diseases, VU University Medical Centre, Amsterdam, Netherlands.; Department of Thoracic Oncology, Netherlands Cancer Institute, Amsterdam, Netherlands., van den Berg A; Department of Pathology and Medical Biology, Groningen, University of Groningen, Groningen, Netherlands., Groen HJM; Department of Pulmonary Diseases, University of Groningen, University Medical Centre Groningen, Groningen, Netherlands.
Publikováno v: PloS one [PLoS One] 2017 Aug 30; Vol. 12 (8), pp. e0182885. Date of Electronic Publication: 2017 Aug 30 (Print Publication: 2017).
Zobrazit plný text záznamu
7
Akademický článek
Non-classic EGFR mutations in a cohort of Dutch EGFR-mutated NSCLC patients and outcomes following EGFR-TKI treatment.
Autor: Kuiper JL; Department of Pulmonary Diseases, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands., Hashemi SM; Department of Pulmonary Diseases, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands., Thunnissen E; Department of Pathology, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands., Snijders PJ; Department of Pathology, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands., Grünberg K; Department of Pathology, Radboud University Medical Center, PO Box 9101, 6500 HB Nijmegen, The Netherlands., Bloemena E; Department of Pathology, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands., Sie D; Department of Pathology, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands., Postmus PE; Clatterbridge Cancer Centre and Liverpool Heart & Chest Hospital, Thomas Drive, Liverpool, Merseyside L14 3PE, UK., Heideman DA; Department of Pathology, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands., Smit EF; Department of Pulmonary Diseases, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands.; Department of Pulmonary Diseases, The Netherlands Cancer Institute, PO Box 90203, 1006 BE Amsterdam, The Netherlands.
Publikováno v: British journal of cancer [Br J Cancer] 2016 Dec 06; Vol. 115 (12), pp. 1504-1512. Date of Electronic Publication: 2016 Nov 22.
Zobrazit plný text záznamu
8
Akademický článek
Rearranged EML4-ALK fusion transcripts sequester in circulating blood platelets and enable blood-based crizotinib response monitoring in non-small-cell lung cancer.
Autor: Nilsson RJ; Cancer Center Amsterdam, Department of Neurosurgery, VU University Medical Center, Amsterdam, The Netherlands.; Department of Radiation Sciences, Oncology, Umeå University, Umeå, Sweden.; ThromboDx B.V., Amsterdam, The Netherlands., Karachaliou N; Translational Research Unit, Dr. Rosell Oncology Institute, Quirón Dexeus University Hospital, Barcelona, Spain., Berenguer J; Cancer Center Amsterdam, Department of Neurosurgery, VU University Medical Center, Amsterdam, The Netherlands., Gimenez-Capitan A; Pangaea Biotech SL, Barcelona, Spain., Schellen P; Cancer Center Amsterdam, Department of Neurosurgery, VU University Medical Center, Amsterdam, The Netherlands.; ThromboDx B.V., Amsterdam, The Netherlands., Teixido C; Pangaea Biotech SL, Barcelona, Spain., Tannous J; Department of Neurology, Massachusetts General Hospital and Neuroscience Program, Harvard Medical School, Boston, MA, USA., Kuiper JL; Cancer Center Amsterdam, Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands., Drees E; Cancer Center Amsterdam, Department of Neurosurgery, VU University Medical Center, Amsterdam, The Netherlands., Grabowska M; Cancer Center Amsterdam, Department of Neurosurgery, VU University Medical Center, Amsterdam, The Netherlands., van Keulen M; Department of Neurology, Massachusetts General Hospital and Neuroscience Program, Harvard Medical School, Boston, MA, USA., Heideman DA; Cancer Center Amsterdam, Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands., Thunnissen E; Cancer Center Amsterdam, Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands., Dingemans AM; Department of Pulmonary Diseases, Maastricht University Medical Center, Maastricht, The Netherlands., Viteri S; Translational Research Unit, Dr. Rosell Oncology Institute, Quirón Dexeus University Hospital, Barcelona, Spain., Tannous BA; Department of Neurology, Massachusetts General Hospital and Neuroscience Program, Harvard Medical School, Boston, MA, USA., Drozdowskyj A; Pivotal, Madrid, Spain., Rosell R; Translational Research Unit, Dr. Rosell Oncology Institute, Quirón Dexeus University Hospital, Barcelona, Spain.; Pangaea Biotech SL, Barcelona, Spain.; Catalan Institute of Oncology, Hospital Germans Trias i Pujol, Barcelona, Spain.; Molecular Oncology Research (MORe) Foundation, Barcelona, Spain., Smit EF; Cancer Center Amsterdam, Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands., Wurdinger T; Cancer Center Amsterdam, Department of Neurosurgery, VU University Medical Center, Amsterdam, The Netherlands.; ThromboDx B.V., Amsterdam, The Netherlands.; Department of Neurology, Massachusetts General Hospital and Neuroscience Program, Harvard Medical School, Boston, MA, USA.
Publikováno v: Oncotarget [Oncotarget] 2016 Jan 05; Vol. 7 (1), pp. 1066-75.
Zobrazit plný text záznamu
9
Akademický článek
Treatment and survival of patients with EGFR-mutated non-small cell lung cancer and leptomeningeal metastasis: A retrospective cohort analysis.
Autor: Kuiper JL; Department of Pulmonary Diseases, VU University Medical Center, Boelelaan 1117, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands. Electronic address: jl.kuiper@vumc.nl., Hendriks LE; Department of Pulmonary Diseases, GROW-School for Developmental Biology & Oncology, Maastricht University Medical Center, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands., van der Wekken AJ; Department of Pulmonary Diseases, University of Groningen and University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands., de Langen AJ; Department of Pulmonary Diseases, VU University Medical Center, Boelelaan 1117, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands; Department of Pulmonary Diseases, Academic Medical Center, P.O. Box 22660, 1100 DD Amsterdam, The Netherlands., Bahce I; Department of Pulmonary Diseases, VU University Medical Center, Boelelaan 1117, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands; Department of Pulmonary Diseases, Academic Medical Center, P.O. Box 22660, 1100 DD Amsterdam, The Netherlands., Thunnissen E; Department of Pathology, VU University Medical Center, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands., Heideman DA; Department of Pathology, VU University Medical Center, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands., Berk Y; Department of Pulmonary Diseases, Canisius Wilhelmina hospital, P.O. Box 9015, 6500 GS Nijmegen, The Netherlands., Buijs EJ; Department of Pulmonary Diseases, VU University Medical Center, Boelelaan 1117, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands., Speel EJ; Department of Pathology, GROW-School for Developmental Biology & Oncology, Maastricht University Medical Center, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands., Krouwels FH; Department of Pulmonary Diseases, Spaarne Hospital, P.O. Box 770, 2130 AT Hoofddorp, The Netherlands., Smit HJ; Department of Pulmonary Diseases, Rijnstate Hospital, P.O. Box 9555, 6800 TA Arnhem, The Netherlands., Groen HJ; Department of Pulmonary Diseases, University of Groningen and University Medical Center Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands., Dingemans AM; Department of Pulmonary Diseases, GROW-School for Developmental Biology & Oncology, Maastricht University Medical Center, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands., Smit EF; Department of Pulmonary Diseases, VU University Medical Center, Boelelaan 1117, P.O. Box 7057, 1007 MB Amsterdam, The Netherlands; Department of Pulmonary Diseases, The Netherlands Cancer Institute, P.O. Box 90203, 1006 BE Amsterdam, The Netherlands.
Publikováno v: Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2015 Sep; Vol. 89 (3), pp. 255-61. Date of Electronic Publication: 2015 Jun 06.
Zobrazit plný text záznamu
10
Report
Transformation to a squamous cell carcinoma phenotype of an EGFR-mutated NSCLC patient after treatment with an EGFR-tyrosine kinase inhibitor.
Autor: Kuiper JL; Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands., Ronden MI; Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands., Becker A; Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands., Heideman DA; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands., van Hengel P; Department of Pulmonary Diseases, Flevo Hospital, Almere, The Netherlands., Ylstra B; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands., Thunnissen E; Department of Pathology, VU University Medical Center, Amsterdam, The Netherlands., Smit EF; Department of Pulmonary Diseases, VU University Medical Center, Amsterdam, The Netherlands Department of Pulmonary Diseases, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Publikováno v: Journal of clinical pathology [J Clin Pathol] 2015 Apr; Vol. 68 (4), pp. 320-1. Date of Electronic Publication: 2015 Feb 06.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje